156 related articles for article (PubMed ID: 11890359)
1. Overview: H3 histamine receptor isoforms: new therapeutic targets in the CNS?
Chazot PL; Hann V
Curr Opin Investig Drugs; 2001 Oct; 2(10):1428-31. PubMed ID: 11890359
[No Abstract] [Full Text] [Related]
2. Histamine-selective H3 receptor ligands and cognitive functions: an overview.
Vohora D
IDrugs; 2004 Jul; 7(7):667-73. PubMed ID: 15243869
[TBL] [Abstract][Full Text] [Related]
3. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
4. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
[TBL] [Abstract][Full Text] [Related]
5. The histamine H3 receptor: from gene cloning to H3 receptor drugs.
Leurs R; Bakker RA; Timmerman H; de Esch IJ
Nat Rev Drug Discov; 2005 Feb; 4(2):107-20. PubMed ID: 15665857
[TBL] [Abstract][Full Text] [Related]
6. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
Witkin JM; Nelson DL
Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
[TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of the histamine H3 receptor.
Bongers G; Bakker RA; Leurs R
Biochem Pharmacol; 2007 Apr; 73(8):1195-204. PubMed ID: 17276412
[TBL] [Abstract][Full Text] [Related]
8. Keynote review: histamine H3 receptor antagonists reach out for the clinic.
Celanire S; Wijtmans M; Talaga P; Leurs R; de Esch IJ
Drug Discov Today; 2005 Dec; 10(23-24):1613-27. PubMed ID: 16376822
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of histamine H3 receptor agonists and antagonists.
Leurs R; Blandina P; Tedford C; Timmerman H
Trends Pharmacol Sci; 1998 May; 19(5):177-83. PubMed ID: 9652190
[TBL] [Abstract][Full Text] [Related]
10. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
11. [The histamine H(3) receptor: a target for new drugs].
Arrang JM
Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
[TBL] [Abstract][Full Text] [Related]
12. Histamine H3-receptor isoforms.
Bakker RA
Inflamm Res; 2004 Oct; 53(10):509-16. PubMed ID: 15597144
[TBL] [Abstract][Full Text] [Related]
13. Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H (3) receptor isoforms.
Esbenshade TA; Krueger KM; Yao BB; Witte DG; Estvander BR; Baranowski JL; Miller TR; Hancock AA
Inflamm Res; 2006 Apr; 55 Suppl 1():S45-6. PubMed ID: 16705378
[No Abstract] [Full Text] [Related]
14. [The histaminergic system: a target for innovative treatments of cognitive deficits].
Motawaj M; Burban A; Davenas E; Gbahou F; Faucard R; Morisset S; Arrang JM
Therapie; 2010; 65(5):415-22. PubMed ID: 21144476
[TBL] [Abstract][Full Text] [Related]
15. Histamine H3 receptor function and ligands: recent developments.
Singh M; Jadhav HR
Mini Rev Med Chem; 2013 Jan; 13(1):47-57. PubMed ID: 22931528
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of histamine H3 receptor antagonists in dementias.
Chazot PL
Drug News Perspect; 2010 Mar; 23(2):99-103. PubMed ID: 20369074
[TBL] [Abstract][Full Text] [Related]
17. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
Esbenshade TA; Fox GB; Cowart MD
Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
[TBL] [Abstract][Full Text] [Related]
18. [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders].
Arrang JM
Ann Pharm Fr; 2007 Jul; 65(4):275-84. PubMed ID: 17652997
[TBL] [Abstract][Full Text] [Related]
19. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
[TBL] [Abstract][Full Text] [Related]
20. Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
Pan JB; Yao BB; Miller TR; Kroeger PE; Bennani YL; Komater VA; Esbenshade TA; Hancock AA; Decker MW; Fox GB
Life Sci; 2006 Aug; 79(14):1366-79. PubMed ID: 16730751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
